New Algorithms to Signal Processing for Speech Enhancement in Adult Cochlear Implant Recipients.

Launched by COCHLEAR · Oct 19, 2023

Keywords

ClinConnect Summary

This clinical trial is exploring new ways to improve how cochlear implants help people hear speech more clearly, especially in noisy environments. Researchers are developing special computer programs designed to enhance speech sounds while reducing background noise. The goal is to make it easier for people with cochlear implants to understand conversations in everyday situations.

To participate, you need to be at least 18 years old and already using a specific type of cochlear implant called the Nucleus system. You should also have been using the implant for at least three months and be able to recognize some speech in a noisy setting. The trial is open to anyone who meets these criteria, regardless of gender or age beyond 18. If you join the study, you’ll be part of a process that could lead to better hearing experiences for cochlear implant users in the future. Your involvement will help researchers understand how these new strategies work in real life.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • User of an approved Nucleus cochlear implant.
• • User of the ACE (Advanced Combination Encoder) sound processing strategy.
• • Aged 18 years or older (no upper age limit).
• • Able to score 20% or more at +10 dB SNR or have an adaptive Speech Recognition Threshold (SRT) of 12 dB or less CI alone on a sentence in babble test.\*
• • Fluent speaker in the language used to assess speech perception performance, as determined by the investigator.
• • Willing and able to provide written informed consent.
• • ≥3 months post cochlear implant activation
• Exclusion Criteria:
• • Unable or unwilling to comply with the requirements of the clinical investigation as determined by the Investigator.
• • Additional health factors, known to the investigator, that would prevent or restrict participation in the audiological evaluations.
• • Investigator site personnel directly affiliated with this study and/or the investigator's immediate families; immediate family is defined as a spouse, parent, child, or sibling.
• • Cochlear employees or employees of Contract Research Organizations or contractors engaged by Cochlear for the purposes of this investigation.
• • Current participation, or participation in another interventional clinical study/trial in the past 30 days, involving an investigational drug or device (unless the other investigation was/is a Cochlear sponsored investigation and determined by the investigator or Sponsor to not impact this investigation).